Valcivir 1000 Tablet

• Herpes labialis
• Genital herpes infection
• Herpes zoster

Every medicine has some side effects that typically manage on their own as your body gets used to the medicine, but some people may experience severe side effects rarely. In that case, the patient should contact the doctor immediately.

Some common side effects of Valcivir 1000 Tablet include:

• Nausea
• Abdominal pain
• Headache
• Increased liver enzymes
• Nasopharyngitis (inflammation of the throat and nasal passages)

• The recommended dose of Valcivir 1000 Tablet may vary according to the type of infection, weight, and other health factors of the patients. This tablet should be swallowed as a whole with water and do not crush, chew, or open it.
• It is usually taken once a day, with or without food, at a fixed time each day. Don't miss a dose or double the dose to compensate for the missed dose.​
  

• Valcivir 1000 Tablet is an antiviral medicine with Valacyclovir (1000mg) as an active ingredient.
• It works by blocking the replication of the virus to reduce its levels in the body. By suppressing viral replication, it helps to slow down the disease progression and clear up the infection.​​
  

• Wu, J. J., Brentjens, M. H., Torres, G., Yeung–Yue, K., Lee, P., & Tyring, S. K. (2003). Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infections. Journal of cutaneous medicine and surgery, 7(5), 372-381. https://pubmed.ncbi.nlm.nih.gov/14505192/
• Tyring, S. K., Baker, D., & Snowden, W. (2002). Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years’ experience with acyclovir. The Journal of infectious diseases, 186(Supplement_1), S40-S46. https://pubmed.ncbi.nlm.nih.gov/12353186/
• Gupta, R., Wald, A., Krantz, E., Selke, S., Warren, T., Vargas-Cortes, M., ... & Corey, L. (2004). Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. The Journal of infectious diseases, 190(8), 1374-1381. https://pubmed.ncbi.nlm.nih.gov/15378428/
• DeJesus, E., Wald, A., Warren, T., Schacker, T. W., Trottier, S., Shahmanesh, M., ... & Valacyclovir International HSV Study Group. (2003). Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus–infected subjects. The Journal of infectious diseases, 188(7), 1009-1016. https://pubmed.ncbi.nlm.nih.gov/14513421/
• Shinkai, I., & Ohta, Y. (1996). Valacyclovir. Bioorganic & medicinal chemistry, 4(1), 1-2.